BioPower Operations Corporation
BOPO · OTC
5/31/2023 | 2/28/2023 | 11/30/2022 | 8/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | 0.05 | -0.01 | -0.01 |
| FCF Yield | -0.00% | -0.02% | -2.30% | 2.73% |
| EV / EBITDA | -31.06 | -107.77 | -1,527.92 | 0.00 |
| Quality | ||||
| ROIC | 110.44% | 3.19% | 11.76% | 9.57% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 100.00% |
| Cash Conversion Ratio | 0.00 | 0.00 | 0.13 | -0.82 |
| Growth | ||||
| Revenue 3-Year CAGR | 499,900.00% | 718,903.25% | 829,857.90% | 58.13% |
| Free Cash Flow Growth | 44.93% | 99.00% | -134.82% | -24.59% |
| Safety | ||||
| Net Debt / EBITDA | -5.43 | -51.69 | -703.80 | 0.00 |
| Interest Coverage | -103.85 | -0.53 | -2.89 | -7.98 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.24 |